Therapy with mTOR Inhibitors in Polyomavirus Allograft Nephropathy (PVAN): A Five Year Follow Up
<p>Polyomavirus nephropathy (PVAN) has a negative impact on renal allograft survival. Therapy options include reduction of immunosuppression and antiviral drugs.</p><p><strong>Aim:</strong> Evaluate the effect ofmTORi based immunosuppression on PVAN. </p><p>...
Saved in:
Main Authors: | Ana Theresa Guanaes Bonini (Author), André Barros Albuquerque Esteves (Author), Leonardo Figueiredo Camargo (Author), Carla Feitosa do Valle (Author), Gabriel Giollo Rivelli (Author), Marcos Vinícius de Sousa (Author), Marilda Mazzali (Author) |
---|---|
Format: | Book |
Published: |
Archives of Organ Transplantation - Peertechz Publications,
2017-03-22.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Polyomavirus</i> nephropathy and Cytomegalovirus nephritis in renal allograft recipients
by: Agrawal Vinita, et al.
Published: (2010) -
BK polyomavirus-associated nephropathy
by: Yo Han Ahn, et al.
Published: (2022) -
Native BK Polyomavirus Nephropathy in an Orthotopic Heart Transplant Patient
by: Zachary M. Thompson MD, et al.
Published: (2023) -
Polyomavirus Associated Nephropathy: Frequency and Graft Survival Analysis in Northeast of Iran
by: Shirin Taraz Jamshidi, et al.
Published: (2021) -
mTOR in Human Diseases
by: Dormond, Olivier
Published: (2019)